ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,427Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 86

$1.63M Total Retail Price of All Prescriptions

Rank: 2 out of 86

1,282 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,282 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

18% of this provider’s 1,282 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

3% of this provider’s 25,795 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 56%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $156 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 1,137 920 1 9
HYDROCODONE-ACETAMINOPHEN 1,074 753 S3 2 8
AMLODIPINE BESYLATE 893 753 3 13
SIMVASTATIN 838 716 4 19
OMEPRAZOLE 774 644 5 12
POLYETHYLENE GLYCOL 3350 683 566 6 35
LEVOTHYROXINE SODIUM 679 604 7 15
ENALAPRIL MALEATE 606 484 8 31
POTASSIUM CHLORIDE 554 465 9 24
HYDROCHLOROTHIAZIDE 479 418 10 22
NEXIUM 478 355 11 21
METFORMIN HCL 470 402 12 23
LISINOPRIL 455 388 13 18
ZOLPIDEM TARTRATE 435 339 14 17
GABAPENTIN 420 336 15 32
METOPROLOL TARTRATE 416 365 16 25
TRAMADOL HCL 412 363 17 34
PREDNISONE 390 291 18 3
WARFARIN SODIUM 380 334 19 26
LOVASTATIN 362 324 20 48
PANTOPRAZOLE SODIUM 358 279 21 28
CITALOPRAM HBR 352 255 22 37
CARVEDILOL 324 289 23 36
DIOVAN 316 263 24 50
DIGOXIN 295 256 25 47
TRIAMTERENE-HCTZ 290 258 26 52
SINGULAIR 289 217 27 7
CEFUROXIME 288 236 28 53
CLOPIDOGREL 286 257 29 41
DONEPEZIL HCL 277 275 30 40
HYDRALAZINE HCL 262 198 31 57
ATORVASTATIN CALCIUM 255 230 32 27
ADVAIR DISKUS 247 169 33 2
GLYBURIDE 245 220 R 34 62
NAMENDA 244 243 35 45
PLAVIX 224 207 36 55
ESCITALOPRAM OXALATE 214 179 37 54
CLONIDINE HCL 214 170 37 59
LYRICA 213 134 39 84
METFORMIN HCL ER 210 154 40 85
ATENOLOL 205 172 41 43
FLUTICASONE PROPIONATE 202 165 42 11
SUCRALFATE 200 172 43 88
KLOR-CON M20 195 160 44 60
LANTUS 187 155 45 92
PAROXETINE HCL 187 156 45 75
TRAZODONE HCL 185 146 47 93
TAMSULOSIN HCL 181 176 48 49
CIPROFLOXACIN HCL 181 151 48 30
RANITIDINE HCL 179 147 50 58
SERTRALINE HCL 178 159 51 64
METOPROLOL SUCCINATE 176 146 52 38
MONTELUKAST SODIUM 171 125 53 16
PROAIR HFA 164 86 54 4
PRAVASTATIN SODIUM 163 144 55 39
BENAZEPRIL HCL 149 118 56 69
GLIMEPIRIDE 145 120 57 66
SPIRIVA 138 124 58 1
ALLOPURINOL 138 105 58 56
ALENDRONATE SODIUM 136 122 60 51
NIFEDIPINE ER 130 88 61 103
ISOSORBIDE MONONITRATE ER 128 111 62 74
TIZANIDINE HCL 126 61 63 104
RISPERIDONE 126 118 63 104
MELOXICAM 119 86 65 73
GUANFACINE HCL 118 107 R 66 107
DOXYCYCLINE HYCLATE 118 82 66 29
VENTOLIN HFA 115 70 68 6
INSULIN SYRINGE 112 79 69 109
PHENYTOIN SODIUM EXTENDED 112 96 69 109
CRESTOR 110 89 71 46
MECLIZINE HCL 110 98 71 111
PROMETHAZINE HCL 110 68 R 71 111
CELEBREX 107 80 74 114
LEVETIRACETAM 107 68 74 114
KLOR-CON 10 106 98 76 116
RAMIPRIL 104 104 77 117
ZETIA 103 81 78 118
JANUVIA 101 86 79 82
MEGESTROL ACETATE 101 84 R 79 119
AMITIZA 98 78 81 121
AMITRIPTYLINE HCL 98 79 R 81 78
VENLAFAXINE HCL ER 97 84 83 122
LEXAPRO 97 78 83 96
CYCLOBENZAPRINE HCL 94 51 R 85 94
SYNTHROID 93 81 86 76
PREMARIN 91 82 R 87 123
CYMBALTA 87 59 88 63
DIOVAN HCT 86 86 89 100
LIPITOR 85 71 90 126
SYMBICORT 83 69 91 5
LANSOPRAZOLE 82 69 92 127
VERAPAMIL ER 82 74 92 127
GEMFIBROZIL 81 62 94 130
DILTIAZEM 24HR ER 80 80 95 131
COMBIVENT 80 71 95 14
COLCRYS 79 64 97 132
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 66 98 87
LOSARTAN POTASSIUM 76 58 99 42
METHENAMINE HIPPURATE 75 67 100 134
NOVOLIN R 70 61 101 141
FAMOTIDINE 68 50 102 98
SPIRONOLACTONE 67 53 103 90
PROPAFENONE HCL 66 54 104 143
AMIODARONE HCL 65 53 105 145
HALOPERIDOL 65 52 105 145
LEVOFLOXACIN 64 44 107 33
AZITHROMYCIN 64 41 107 9
IPRATROPIUM BROMIDE 61 54 109 65
METOLAZONE 61 51 109 151
OXYBUTYNIN CHLORIDE 60 41 111 152
LEVEMIR 59 34 112 154
LABETALOL HCL 59 55 112 108
FENTANYL 58 54 S2 114 156
LUNESTA 57 51 115 157
CILOSTAZOL 57 47 115 157
THEOPHYLLINE ANHYDROUS 55 41 117 20
TERAZOSIN HCL 55 51 117 161
AMOX TR-POTASSIUM CLAVULANATE 55 39 117 86
GLIPIZIDE 53 39 120 165
PROPRANOLOL HCL 53 37 120 165
DIVALPROEX SODIUM 52 47 122 169
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.